Results
|
701.
|
|
|
702.
|
|
|
703.
|
Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors. [electronic resource] by
- Schenkel, Laurie B
- Huang, Xin
- Cheng, Alan
- Deak, Holly L
- Doherty, Elizabeth
- Emkey, Renee
- Gu, Yan
- Gunaydin, Hakan
- Kim, Joseph L
- Lee, Josie
- Loberg, Robert
- Olivieri, Philip
- Pistillo, Jeanne
- Tang, Jin
- Wan, Qian
- Wang, Hui-Ling
- Wang, Shen-Wu
- Wells, Mary C
- Wu, Bin
- Yu, Violeta
- Liu, Liqin
- Geuns-Meyer, Stephanie
Producer: 20120308
In:
Journal of medicinal chemistry vol. 54
Availability: No items available.
|
|
704.
|
|
|
705.
|
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis. [electronic resource] by
- Mascarenhas, John O
- Talpaz, Moshe
- Gupta, Vikas
- Foltz, Lynda M
- Savona, Michael R
- Paquette, Ronald
- Turner, A Robert
- Coughlin, Paul
- Winton, Elliott
- Burn, Timothy C
- O'Neill, Peter
- Clark, Jason
- Hunter, Deborah
- Assad, Albert
- Hoffman, Ronald
- Verstovsek, Srdan
Producer: 20170707
In:
Haematologica vol. 102
Availability: No items available.
|
|
706.
|
|
|
707.
|
|
|
708.
|
|
|
709.
|
|
|
710.
|
|
|
711.
|
|
|
712.
|
|
|
713.
|
Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules. [electronic resource] by
- Shimokawa, T
- Seike, M
- Soeno, C
- Uesaka, H
- Miyanaga, A
- Mizutani, H
- Kitamura, K
- Minegishi, Y
- Noro, R
- Okano, T
- Yoshimura, A
- Gemma, A
Producer: 20120418
In:
British journal of cancer vol. 106
Availability: No items available.
|
|
714.
|
Janus kinases 1 and 2 regulate chemokine-mediated integrin activation and naïve T-cell homing. [electronic resource] by
- Pérez-Rivero, Gema
- Cascio, Graciela
- Soriano, Silvia Fernández
- Sanz, Álvaro Gil
- de Guinoa, Julia Sáez
- Rodríguez-Frade, José Miguel
- Gomariz, Rosa P
- Holgado, Borja L
- Cabañas, Carlos
- Carrasco, Yolanda R
- Stein, Jens V
- Mellado, Mario
Producer: 20130909
In:
European journal of immunology vol. 43
Availability: No items available.
|
|
715.
|
|
|
716.
|
|
|
717.
|
|
|
718.
|
|
|
719.
|
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus. [electronic resource] by
- Kahl, L
- Patel, J
- Layton, M
- Binks, M
- Hicks, K
- Leon, G
- Hachulla, E
- Machado, D
- Staumont-Sallé, D
- Dickson, M
- Condreay, L
- Schifano, L
- Zamuner, S
- van Vollenhoven, R F
Producer: 20170530
In:
Lupus vol. 25
Availability: No items available.
|
|
720.
|
|